Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
CEO Greg Behar said recent investments and partnerships have significantly expanded the global CDMO’s capacity in key areas such as pre-filled syringes and lyophilization.
Located at its global headquarters in Craigavon, the new 100,000-square-foot facility augments Almac’s capabilities in the manufacture of oral dose treatments.
The investment supports the construction of an R&D and manufacturing hub to advance Entos’ Fusogenix PLV drug delivery platform and expand Canadian biomanufacturing capacity.
Plant 5 will be operational in April and the CDMO is moving forward with plans for the construction of Plant 6 to “maintain the world’s No. 1 manufacturing capacity.”
William Blair analyst Andy Hsieh in a note to investors said the comprehensive agreement mitigates supply chain risk for Viking’s VK2735 dual GLP-1/GIP agonist.
The Montreal-based company is vulnerable to potential tariffs from President Donald Trump and Canada’s government that could adversely affect its financial results.
Part of Vetter’s Center for Visual Inspection and Logistics, construction of the 22,500-square-meter extension began in late 2024, with completion expected by 2028.
Purdue’s Young Institute Pharmaceutical Manufacturing Consortium is working to address bottlenecks in efficiency, contamination control, and regulatory compliance.
The partnership integrates Asimov’s CHO Edge platform, which uses synthetic biology and AI to optimize Chinese hamster ovary cell lines for antibody and protein production.
By automating and digitizing critical processes, Ori’s platform is designed to streamline manufacturing workflows and overcome bottlenecks that currently limit patient access....
